Relay Therapeutics | IPO Presentation Deck | 25 slides · page 14 of 25
Includes preclinical data comparing RLY-4008 to Pemigatinib, Infigratinib, and TAS-120.
Pitch deck · solution · present_solution · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
callout 3/3 chart 3/3 paragraph 1/1 source-note 1/1 title 1/1
Components 9
primary primary primary bar-horizontal bar-vertical line paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.